Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Early Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (50.0%)Phase 2
1 (50.0%)An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD
- First Posted Date
- 2014-08-29
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- FerruMax Pharmaceuticals, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT02228655
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD
- First Posted Date
- 2013-06-10
- Last Posted Date
- 2015-08-11
- Lead Sponsor
- FerruMax Pharmaceuticals, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT01873534
- Locations
- 🇺🇸
DaVita Arvada Dialysis Center, Arvada, Colorado, United States
🇺🇸DaVita Minneapolis Dialysis Unit, Minneapolis, Minnesota, United States
News
No news found